Rosenberg Aaron 4
4 · BeiGene, Ltd. · Filed Aug 13, 2024
Insider Transaction Report
Form 4
BeiGene, Ltd.BGNE
Rosenberg Aaron
Chief Financial Officer
Transactions
- Award
Ordinary Shares
2024-08-09+118,547→ 118,547 total - Award
Share Option (Right to Buy)
2024-08-09+220,987→ 220,987 totalExercise: $14.06Exp: 2034-08-08→ Ordinary Shares (220,987 underlying)
Footnotes (3)
- [F1]Represents securities underlying restricted share units. 1/4th of the securities will vest on each anniversary of July 31, 2024, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events.
- [F2]The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. Each American Depositary Share represents 13 ordinary shares.
- [F3]These securities vest over a four-year period as follows: 25% on the first anniversary of July 31, 2024 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events.